- Conditions
- Autism
- Interventions
- Online Parent Training in Early Behavioral Intervention (OPT-In-Early)
- Behavioral
- Lead sponsor
- Drexel University
- Other
- Eligibility
- 16 Months to 48 Months
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 2,118
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Small Cell Lung Carcinoma
- Interventions
- Regorafenib (BAY73-4506) - sequential / Cisplatin / Pemetrexed, Regorafenib (BAY73-4506) - continuous / Cisplatin / Pemetrexed
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 4
- States / cities
- New Haven, Connecticut • Las Vegas, Nevada • New York, New York + 1 more
- Conditions
- Autism Spectrum Disorder, Physical Activity, Anxiety, Mobile Health
- Interventions
- Mobile Health for Physical Activity Behavior Change
- Behavioral
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Bloomington, Indiana
- Conditions
- Parkinson Disease, Huntington Disease, Autistic Spectrum Disorders, Fragile X Syndrome, Alzheimer Disease, Mild Cognitive Impairment
- Interventions
- [18F]FPEB
- Drug
- Lead sponsor
- Institute for Neurodegenerative Disorders
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2016
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Autism, Autism Spectrum Disorder
- Interventions
- GuessWhat Mobile App
- Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 541 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Epithelial Ovarian Cancer, Primary Peritoneal Cancer
- Interventions
- Topotecan, Cisplatin, Paclitaxel
- Drug
- Lead sponsor
- John P. Fruehauf
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Orange, California
- Conditions
- Autism, Enuresis, Incontinence
- Interventions
- Wireless Moisture Pager (WMP)
- Device
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 3 Years to 6 Years
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 3
- States / cities
- Rochester, New York • Columbus, Ohio • Nashville, Tennessee
- Conditions
- Autism Spectrum Disorder
- Interventions
- N-Acetylcysteine
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2029
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Autism Spectrum Disorder
- Interventions
- Transcranial infrared light stimulation, Sham
- Device
- Lead sponsor
- Francisco Gonzalez-Lima, PhD
- Other
- Eligibility
- 4 Years to 60 Years
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Behavioral Symptoms, Autistic Disorder
- Interventions
- Aripiprazole, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 218 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 31
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 28 more
- Conditions
- Autism Spectrum Disorder
- Interventions
- Not listed
- Lead sponsor
- Yale University
- Other
- Eligibility
- 3 Years to 5 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 5
- States / cities
- Los Angeles, California • New Haven, Connecticut • Boston, Massachusetts + 2 more
- Conditions
- Autism, Minocycline, Regressive Autism
- Interventions
- Minocycline
- Drug
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Eligibility
- 3 Years to 12 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2011
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia • Bethesda, Maryland
- Conditions
- Autism Spectrum Disorder
- Interventions
- Melatonin
- Dietary Supplement
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 12 Years to 18 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Autism
- Interventions
- Buspirone
- Drug
- Lead sponsor
- Chugani, Diane C.
- Individual
- Eligibility
- 2 Years to 6 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Self-Injurious Behavior, Problem Behavior, Intellectual Disability, Autism Spectrum Disorder, Restricted Behavior
- Interventions
- AUTOSIB across time, AUTOSIB diminished reinforcement
- Behavioral
- Lead sponsor
- University of Georgia
- Other
- Eligibility
- 2 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Randolph, Massachusetts
- Conditions
- Autism Spectrum Disorder, Disruptive Behavior
- Interventions
- RUBI, RUBIES
- Behavioral
- Lead sponsor
- University of Washington
- Other
- Eligibility
- Not listed
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Calcitriol
- Drug
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2013
- U.S. locations
- 4
- States / cities
- Ann Arbor, Michigan • Buffalo, New York
- Conditions
- Rett Syndrome
- Interventions
- NNZ-2566, Placebo
- Drug
- Lead sponsor
- Neuren Pharmaceuticals Limited
- Industry
- Eligibility
- 16 Years to 45 Years · Female only
- Enrollment
- 67 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Saint Paul, Minnesota • Houston, Texas
- Conditions
- Autism
- Interventions
- Eyelink Portable Duo
- Diagnostic Test
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 12 Months to 48 Months
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Autism, Developmental Delay Disorders
- Interventions
- Family Navigation, Conventional Care Management
- Behavioral
- Lead sponsor
- Boston University
- Other
- Eligibility
- 15 Months to 27 Months
- Enrollment
- 340 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 10
- States / cities
- New Haven, Connecticut • Boston, Massachusetts • Chelsea, Massachusetts + 2 more
- Conditions
- Autistic Disorder
- Interventions
- Methyl B12, Placebo
- Drug · Dietary Supplement
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 3 Years to 7 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Cervical Cancer
- Interventions
- cisplatin, topotecan hydrochloride
- Drug
- Lead sponsor
- Gynecologic Oncology Group
- Network
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 1999
- U.S. locations
- 8
- States / cities
- Indianapolis, Indiana • Des Moines, Iowa • Papillion, Nebraska + 3 more
- Conditions
- Brain and Central Nervous System Tumors, Pediatric Germ Cell Tumor, Extragonadal Germ Cell Tumor
- Interventions
- cisplatin, etoposide, conventional surgery, neoadjuvant therapy, radiation therapy
- Drug · Procedure · Radiation
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 3 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1991 – 2005
- U.S. locations
- 3
- States / cities
- Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota
- Conditions
- Autism Spectrum Disorder
- Interventions
- Reciprocal Imitation Training (Therapist-Delivered), Reciprocal Imitation Training (Therapist + Parent Delivered)
- Behavioral
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 24 Months to 60 Months
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- Columbus, Ohio